Totally agree, the instos couldn't chair less for only 30%, they want a lot more! At the end of the day, this is still super cheap and nothing else mattress, as it will rerate in due course.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025